8-Hydroxydeoxyguanosine: a new potential independent prognostic factor in breast cancer
Open Access
- 23 February 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 102 (6), 1018-1023
- https://doi.org/10.1038/sj.bjc.6605565
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized MedicineThe Oncologist, 2009
- Dual roles of Nrf2 in cancerPharmacological Research, 2008
- RNAi-Mediated Silencing of Nuclear Factor Erythroid-2–Related Factor 2 Gene Expression in Non–Small Cell Lung Cancer Inhibits Tumor Growth and Increases Efficacy of ChemotherapyCancer Research, 2008
- 8‐Hydroxy‐2′‐deoxyguanosine (8‐OH‐dG) as a potential survival biomarker in patients with nonsmall‐cell lung cancerCancer, 2006
- Oxidative Damage to DNA in Non-Malignant Disease: Biomarker or Biohazard?Published by S. Karger AG ,2006
- Impaired removal of 8-hydroxydeoxyguanosine induced by UVB radiation in naevoid basal cell carcinoma syndrome cellsBritish Journal of Dermatology, 2005
- DNA repair is responsible for the presence of oxidatively damaged DNA lesions in urineMutation Research, 2005
- P53, apoptosis, and breast cancerJournal of Mammary Gland Biology and Neoplasia, 1996
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- The reaction of rabbits to rous sarcoma virusInternational Journal of Cancer, 1966